Total medical devices industry cross border deals worth $4.4bn were announced globally for August 2022, with the Bain Capital’s $3.12bn private equity deal with Evident being the sector’s biggest investment, according to GlobalData’s deals database.
The value marked an increase of 69.5% over the previous month of $2.59bn and a rise of 27.6% when compared with the last 12-month average of $3.44bn.
In terms of number of cross border deals, the sector saw a drop of 33.33% with 40 deals in August 2022 when compared to the last 12-month average of 60 deals.
In value terms, Asia-Pacific led the activity with cross border deals worth $3.18bn in August 2022.